<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/704"/><api:result><api:object category="publication" id="704" last-affected-when="2024-03-14T05:52:39.54+00:00" last-modified-when="2024-03-14T05:52:39.54+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/704" created-when="2010-05-17T13:46:27.487+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>1999-05-01</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1518139" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1038/eye.1999.79" last-modified-when="2023-05-20T05:58:40.2+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Lawry</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Currie</api:last-name><api:initials>Z</api:initials><api:first-names>Z</api:first-names><api:separate-first-names><api:first-name>Z</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Smith</api:last-name><api:initials>MO</api:initials><api:first-names>MO</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>O</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1883" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1883"/></api:links><api:last-name>Rennie</api:last-name><api:initials>IG</api:initials><api:first-names>IG</api:first-names><api:separate-first-names><api:first-name>I</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/eye.1999.79</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/eye.1999.79"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/eye.1999.79"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1476-5454</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973898"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0950-222X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973898"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Eye</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>301</api:begin-page><api:end-page>308</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>5</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Science and Business Media LLC</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1038/eye.1999.79</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>18</api:day><api:month>5</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The correlation between cell surface markers and clinical features in choroidal malignant melanomas</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record><api:record format="native" id="704" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10624422" last-modified-when="2020-04-28T21:31:29.28+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>PURPOSE: Uveal melanoma continues to present problems when attempting to predict disease progression. This study attempts to identify markers indicative of the biological characteristics of cells isolated from samples of uveal melanoma, including adhesion (ICAM-1), immune reactivity (MHC Class I and II), cell cycle control (c-erbB-2, c-myc) and apoptosis control (bcl-2, p53) using dual parameter (DNA/MoAb) flow cytometry. METHODS: Sixty-three fresh tissue samples from choroidal melanomas were taken at enucleation. Samples were assayed for DNA content and cell cycle, the above antibodies together with positive (PHM-5) and negative (2 degrees FITC Ab) controls. The clinical parameters sex, age, tumour location, cell type, tumour volume and presence of metastases were compared with the results and analysed with the non-parametric Mann-Whitney U-t-test. RESULTS: ICAM-1 expression proved to be the most clinically relevant, being present on a higher proportion of cells in tumours &gt; 2000 mm3 (median 38, n = 19) compared with the smaller tumours &lt; 2000 mm3 (median 17, n = 26) (p = 0.0015). Metastatic disease was present in 11 patients and did not correlate with any of the surface markers. C-myc, c-erbB-2 and MHC Class II expression were associated with cell type, all showing greater expression in spindle cell tumours than mixed/epithelial types. CONCLUSION: These results show flow cytometry as a quick, easy method to provide a 'phenotypic profile' for these tumours, and identifies cell cycle control and adhesion molecule expression as important areas for further investigation. c-erbB-2 and bcl-2 positivity was typically seen on over 60% cells in each sample, indicating two potential targets for therapeutic intervention.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Lawry</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Institute for Cancer Studies, University Medical School, Sheffield, UK. j.lawry@sheffield.ac.uk</api:line></api:address></api:addresses><api:email-address>j.lawry@sheffield.ac.uk</api:email-address></api:person><api:person><api:last-name>Currie</api:last-name><api:initials>Z</api:initials><api:first-names>Z</api:first-names><api:separate-first-names><api:first-name>Z</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Smith</api:last-name><api:initials>MO</api:initials><api:first-names>MO</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>O</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1883" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1883"/></api:links><api:last-name>Rennie</api:last-name><api:initials>IG</api:initials><api:first-names>IG</api:first-names><api:separate-first-names><api:first-name>I</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10624422</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/eye.1999.79</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/eye.1999.79"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/eye.1999.79"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0950-222X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973898"/></api:links></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Eye (Lond)</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh">Biomarkers, Tumor</api:keyword><api:keyword scheme="mesh">Choroid Neoplasms</api:keyword><api:keyword scheme="mesh">DNA, Neoplasm</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Flow Cytometry</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Intercellular Adhesion Molecule-1</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Melanoma</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Neoplasm Proteins</api:keyword><api:keyword scheme="mesh">Ploidies</api:keyword><api:keyword scheme="mesh">Proto-Oncogene Proteins</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>301</api:begin-page><api:end-page>308</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>14</api:day><api:month>1</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The correlation between cell surface markers and clinical features in choroidal malignant melanomas.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13 ( Pt 3a)</api:text></api:field></api:native></api:record><api:record format="native" id="882014" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10624422" last-modified-when="2021-06-22T17:41:59.393+01:00"><api:citation-count>7</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;h4&gt;Purpose&lt;/h4&gt;Uveal melanoma continues to present problems when attempting to predict disease progression. This study attempts to identify markers indicative of the biological characteristics of cells isolated from samples of uveal melanoma, including adhesion (ICAM-1), immune reactivity (MHC Class I and II), cell cycle control (c-erbB-2, c-myc) and apoptosis control (bcl-2, p53) using dual parameter (DNA/MoAb) flow cytometry.&lt;h4&gt;Methods&lt;/h4&gt;Sixty-three fresh tissue samples from choroidal melanomas were taken at enucleation. Samples were assayed for DNA content and cell cycle, the above antibodies together with positive (PHM-5) and negative (2 degrees FITC Ab) controls. The clinical parameters sex, age, tumour location, cell type, tumour volume and presence of metastases were compared with the results and analysed with the non-parametric Mann-Whitney U-t-test.&lt;h4&gt;Results&lt;/h4&gt;ICAM-1 expression proved to be the most clinically relevant, being present on a higher proportion of cells in tumours &gt; 2000 mm3 (median 38, n = 19) compared with the smaller tumours &lt; 2000 mm3 (median 17, n = 26) (p = 0.0015). Metastatic disease was present in 11 patients and did not correlate with any of the surface markers. C-myc, c-erbB-2 and MHC Class II expression were associated with cell type, all showing greater expression in spindle cell tumours than mixed/epithelial types.&lt;h4&gt;Conclusion&lt;/h4&gt;These results show flow cytometry as a quick, easy method to provide a 'phenotypic profile' for these tumours, and identifies cell cycle control and adhesion molecule expression as important areas for further investigation. c-erbB-2 and bcl-2 positivity was typically seen on over 60% cells in each sample, indicating two potential targets for therapeutic intervention.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Institute for Cancer Studies, University Medical School, Sheffield, UK. j.lawry@sheffield.ac.uk</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Lawry</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Currie</api:last-name><api:initials>Z</api:initials><api:first-names>Z</api:first-names><api:separate-first-names><api:first-name>Z</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Smith</api:last-name><api:initials>MO</api:initials><api:first-names>MO</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>O</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1883" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1883"/></api:links><api:last-name>Rennie</api:last-name><api:initials>IG</api:initials><api:first-names>IG</api:first-names><api:separate-first-names><api:first-name>I</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/eye.1999.79</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/eye.1999.79"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/eye.1999.79"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1476-5454</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973898"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10624422</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0950-222X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973898"/></api:links></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Eye (London, England)</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Melanoma</api:keyword><api:keyword scheme="mesh">Choroid Neoplasms</api:keyword><api:keyword scheme="mesh">Intercellular Adhesion Molecule-1</api:keyword><api:keyword scheme="mesh">Neoplasm Proteins</api:keyword><api:keyword scheme="mesh">Proto-Oncogene Proteins</api:keyword><api:keyword scheme="mesh">DNA, Neoplasm</api:keyword><api:keyword scheme="mesh">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh">Flow Cytometry</api:keyword><api:keyword scheme="mesh">Ploidies</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Biomarkers, Tumor</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>301</api:begin-page><api:end-page>308</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>7</api:day><api:month>1</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The correlation between cell surface markers and clinical features in choroidal malignant melanomas.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13 ( Pt 3a)</api:text></api:field></api:native></api:record><api:record format="native" id="2517981" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1021408830" last-modified-when="2023-12-21T12:41:46.787+00:00"><api:citation-count>8</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Lawry</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0712144264.99</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person><api:person><api:last-name>Currie</api:last-name><api:initials>Z</api:initials><api:first-names>Z</api:first-names><api:separate-first-names><api:first-name>Z</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Royal Hallamshire Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01333165707.14</api:identifier></api:identifiers></api:person><api:person><api:last-name>Smith</api:last-name><api:initials>MO</api:initials><api:first-names>MO</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>O</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0626123755.11</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1883" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1883"/></api:links><api:last-name>Rennie</api:last-name><api:initials>IG</api:initials><api:first-names>IG</api:first-names><api:separate-first-names><api:first-name>I</api:first-name><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Royal Hallamshire Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0721152077.11</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/eye.1999.79</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/eye.1999.79"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/eye.1999.79"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10624422</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0950-222X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973898"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Eye</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="for-2020">3212 Ophthalmology and Optometry</api:keyword><api:keyword scheme="rcdc">Genetics</api:keyword><api:keyword scheme="rcdc">Clinical Research</api:keyword><api:keyword scheme="hrcs-rac">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-hc">Cancer</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh">Biomarkers, Tumor</api:keyword><api:keyword scheme="mesh">Choroid Neoplasms</api:keyword><api:keyword scheme="mesh">DNA, Neoplasm</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Flow Cytometry</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Intercellular Adhesion Molecule-1</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Melanoma</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Neoplasm Proteins</api:keyword><api:keyword scheme="mesh">Ploidies</api:keyword><api:keyword scheme="mesh">Proto-Oncogene Proteins</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Bronze OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>301</api:begin-page><api:end-page>308</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>5</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Nature</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.18</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>The correlation between cell surface markers and clinical features in choroidal malignant melanomas</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record><api:record format="native" id="240375" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000081374300004" last-modified-when="2024-03-14T05:52:39.547+00:00"><api:citation-count>7</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Lawry</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Currie</api:last-name><api:initials>Z</api:initials><api:first-names>Z</api:first-names><api:separate-first-names><api:first-name>Z</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Smith</api:last-name><api:initials>MO</api:initials><api:first-names>MO</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>O</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1883" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1883"/></api:links><api:last-name>Rennie</api:last-name><api:initials>IG</api:initials><api:first-names>IG</api:first-names><api:separate-first-names><api:first-name>I</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000081374300004&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/eye.1999.79</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/eye.1999.79"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/eye.1999.79"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">215GV</api:identifier><api:identifier scheme="pubmed">10624422</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0950-222X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973898"/></api:links></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>EYE</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>antibodies</api:keyword><api:keyword>flow cytometry</api:keyword><api:keyword>melanoma</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>301</api:begin-page><api:end-page>308</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>The correlation between cell surface markers and clinical features in choroidal malignant melanomas</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record><api:record format="native" id="23053" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000081374300004" last-modified-when="2014-07-25T11:05:07.62+01:00"><api:citation-count>5</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Lawry</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Currie</api:last-name><api:initials>Z</api:initials><api:first-names>Z</api:first-names><api:separate-first-names><api:first-name>Z</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Smith</api:last-name><api:initials>MO</api:initials><api:first-names>MO</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>O</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1883" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1883"/></api:links><api:last-name>Rennie</api:last-name><api:initials>IG</api:initials><api:first-names>IG</api:first-names><api:separate-first-names><api:first-name>I</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0950-222X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973898"/></api:links></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>EYE</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>antibodies</api:keyword><api:keyword>flow cytometry</api:keyword><api:keyword>melanoma</api:keyword><api:keyword>MYC ONCOGENE EXPRESSION</api:keyword><api:keyword>UVEAL MELANOMA</api:keyword><api:keyword>FLOW-CYTOMETRY</api:keyword><api:keyword>C-MYC</api:keyword><api:keyword>BREAST-CANCER</api:keyword><api:keyword>RECEPTOR</api:keyword><api:keyword>C-ERBB-2</api:keyword><api:keyword>PLOIDY</api:keyword><api:keyword>CYCLE</api:keyword><api:keyword>P53</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>301</api:begin-page><api:end-page>308</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The correlation between cell surface markers and clinical features in choroidal malignant melanomas</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Biomarkers, Tumor</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Choroid Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">DNA, Neoplasm</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Flow Cytometry</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Intercellular Adhesion Molecule-1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Melanoma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Neoplasm Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Ploidies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Proto-Oncogene Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Melanoma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Choroid Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Intercellular Adhesion Molecule-1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Neoplasm Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Proto-Oncogene Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">DNA, Neoplasm</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Flow Cytometry</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Ploidies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Biomarkers, Tumor</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3212 Ophthalmology and Optometry</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Genetics</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Clinical Research</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Biomarkers, Tumor</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Choroid Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">DNA, Neoplasm</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Flow Cytometry</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Intercellular Adhesion Molecule-1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Melanoma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Neoplasm Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Ploidies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Proto-Oncogene Proteins</api:keyword><api:keyword origin="record-data" source="wos-lite">antibodies</api:keyword><api:keyword origin="record-data" source="wos-lite">flow cytometry</api:keyword><api:keyword origin="record-data" source="wos-lite">melanoma</api:keyword><api:keyword origin="record-data" source="wos">antibodies</api:keyword><api:keyword origin="record-data" source="wos">flow cytometry</api:keyword><api:keyword origin="record-data" source="wos">melanoma</api:keyword><api:keyword origin="record-data" source="wos">MYC ONCOGENE EXPRESSION</api:keyword><api:keyword origin="record-data" source="wos">UVEAL MELANOMA</api:keyword><api:keyword origin="record-data" source="wos">FLOW-CYTOMETRY</api:keyword><api:keyword origin="record-data" source="wos">C-MYC</api:keyword><api:keyword origin="record-data" source="wos">BREAST-CANCER</api:keyword><api:keyword origin="record-data" source="wos">RECEPTOR</api:keyword><api:keyword origin="record-data" source="wos">C-ERBB-2</api:keyword><api:keyword origin="record-data" source="wos">PLOIDY</api:keyword><api:keyword origin="record-data" source="wos">CYCLE</api:keyword><api:keyword origin="record-data" source="wos">P53</api:keyword><api:keyword scheme="for" origin="issn-inferred">1103 Clinical Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">1107 Immunology</api:keyword><api:keyword scheme="for" origin="issn-inferred">1113 Opthalmology and Optometry</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Ophthalmology &amp; Optometry</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3204 Immunology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3212 Ophthalmology and optometry</api:keyword></api:keywords></api:all-labels><api:journal issn="0950-222X" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973898" title="Eye"><api:records><api:record source-name="summary"><api:title>Eye</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/704/relationships"/></api:object></api:result></api:response>